IPO Champ helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Champ
IPO Champ is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
help@ipochamp.com.
Please read all offer documents and risk disclosures carefully before investing. IPO Champ does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Champ. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane WestThree other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic servicesBasic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panelsSpecialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
National Stock Exchange of India
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
National Stock Exchange of India Mainboard | 17th Sep 2026 - 21st Sep 2026 | 22561.57 Cr | 8 Shares | ₹ 1700.00 | |
Antala Industries SME | 29th Oct 2026 - 5th Nov 2026 | 22.98 Cr | 2000 Shares | ₹ 62.00 |

Open Date
01 Dec 2025
Close Date
03 Dec 2025
Min Investment
₹272000
Lot Size
3200 Shares
Issue Size
₹28.12 Cr
Price Range
₹80 - ₹85
Listing Date
Dec 8, 2025
IPO Doc
RHP PDFRevenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
21.11 crore will fund new medical equipment and five diagnostic centres in Maharashtra. Part of the IPO proceeds will be used for general corporate purposes
Capital Expenditure Requirements
75.07%
General corporate purposes
24.93%
21.11 crore will fund new medical equipment and five diagnostic centres in Maharashtra.
Part of the IPO proceeds will be used for general corporate purposes
Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).
In Cr.
| Key Performance Indicator | 30-Sep-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) |
|---|---|---|---|
| Revenue | 17.08 | 30.18 | 15.90 |
| EBITDA | 6.77 | 9.20 | 7.09 |
| Expenses | |||
| Profit After Tax | 4.08 | 4.93 | 3.81 |
| Assets | 34.90 | 21.22 | 15.89 |
| Net Worth | 23.68 | 13.60 | 8.67 |
| Reserves | 14.42 | 5.18 | 8.54 |
| Borrowing | 3.72 | 3.54 | 3.81 |
Dr. Ketan Jayantilal Jain
Dr. Sanket Vinod Jain
Rohit Prakash Srivastava
Badal Kailash Naredi
Jayesh Prakash Jain
N/A
N/A
Invicta Diagnostic
1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013
Bigshare Services Pvt Ltd